Armor Investment Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.43M | Hold |
1,557
| – | – | 0.52% | 40 |
|
|
2025
Q4 | $1.67M | Sell |
1,557
-150
| -9% | -$143K | 0.62% | 36 |
|
|
2025
Q3 | $1.3M | Hold |
1,707
| – | – | 0.41% | 47 |
|
|
2025
Q2 | $1.33M | Sell |
1,707
-9
| -0.5% | -$6.99K | 0.5% | 44 |
|
|
2025
Q1 | $1.42M | Sell |
1,716
-18
| -1% | -$15K | 0.59% | 40 |
|
|
2024
Q4 | $1.34M | Buy |
1,734
+68
| +4% | +$56.3K | 0.55% | 43 |
|
|
2024
Q3 | $1.48M | Hold |
1,666
| – | – | 0.61% | 39 |
|
|
2024
Q2 | $1.51M | Sell |
1,666
-1
| -0.1% | -$800 | 0.7% | 42 |
|
|
2024
Q1 | $1.3M | Buy |
1,667
+5
| +0.3% | +$3.56K | 0.62% | 46 |
|
|
2023
Q4 | $969K | Sell |
1,662
-589
| -26% | -$344K | 0.51% | 49 |
|
|
2023
Q3 | $1.21M | Buy |
2,251
+5
| +0.2% | +$2.58K | 0.72% | 42 |
|
|
2023
Q2 | $1.05M | Buy |
2,246
+6
| +0.3% | +$2.52K | 0.64% | 44 |
|
|
2023
Q1 | $769K | Sell |
2,240
-215
| -9% | -$72.5K | 0.44% | 55 |
|
|
2022
Q4 | $898K | Buy |
2,455
+76
| +3% | +$26.9K | 0.55% | 48 |
|
|
2022
Q3 | $769K | Buy |
2,379
+42
| +2% | +$13.3K | 0.52% | 49 |
|
|
2022
Q2 | $758K | Hold |
2,337
| – | – | 0.49% | 53 |
|
|
2022
Q1 | $669K | Hold |
2,337
| – | – | 0.38% | 66 |
|
|
2021
Q4 | $646K | Hold |
2,337
| – | – | 0.36% | 70 |
|
|
2021
Q3 | $540K | Hold |
2,337
| – | – | 0.34% | 74 |
|
|
2021
Q2 | $536K | Hold |
2,337
| – | – | 0.32% | 74 |
|
|
2021
Q1 | $437K | Hold |
2,337
| – | – | 0.28% | 77 |
|
|
2020
Q4 | $395K | Buy |
+2,337
| New | +$349K | 0.28% | 79 |
|
|
2020
Q3 | – | Sell |
-2,337
| Closed | -$384K | – | 142 |
|
|
2020
Q2 | $384K | Hold |
2,337
| – | – | 0.33% | 66 |
|
|
2020
Q1 | $324K | Hold |
2,337
| – | – | 0.33% | 65 |
|
|
2019
Q4 | $307K | Hold |
2,337
| – | – | 0.24% | 81 |
|
|
2019
Q3 | $261K | Hold |
2,337
| – | – | 0.21% | 82 |
|
|
2019
Q2 | $259K | Hold |
2,337
| – | – | 0.22% | 81 |
|
|
2019
Q1 | $303K | Hold |
2,337
| – | – | 0.26% | 76 |
|
|
2018
Q4 | $270K | Sell |
2,337
-259
| -10% | -$28.9K | 0.27% | 75 |
|
|
2018
Q3 | $279K | Hold |
2,596
| – | – | 0.25% | 87 |
|
|
2018
Q2 | $222K | Sell |
2,596
-300
| -10% | -$24.6K | 0.2% | 93 |
|
|
2018
Q1 | $224K | Buy |
+2,896
| New | +$233K | 0.2% | 94 |
|
|
2017
Q4 | – | Sell |
-2,337
| Closed | -$200K | – | 152 |
|
|
2017
Q3 | $200K | Buy |
+2,337
| New | +$192K | 0.19% | 94 |
|
Other funds holding LLY
VCM
VPM
Armor Investment Advisors's LLY Position: Q1 2026 in Review
Armor Investment Advisors held its Eli Lilly (LLY) position steady in Q1 2026 at 1,557 shares worth $1.43M. The position accounts for 0.52% of the portfolio, ranked #40.
Armor Investment Advisors first reported a position in LLY in Q3 2017 and has held it in 33 quarters since. The position peaked at $1.67M in Q4 2025. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Armor Investment Advisors held 1,557 shares of Eli Lilly worth $1.43M as of Q1 2026.
- Armor Investment Advisors left its Eli Lilly share count unchanged in Q1 2026.
- Eli Lilly made up 0.52% of Armor Investment Advisors's portfolio in Q1 2026, its #40 holding.
- Armor Investment Advisors first reported a position in Eli Lilly in Q3 2017 and has held it in 33 quarters since.
- Armor Investment Advisors's Eli Lilly position peaked at $1.67M in Q4 2025.
- 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Armor Investment Advisors's 13F filing for Q1 2026, filed 29 Apr 2026.